Monteris Medical Facilitates TRICARE Coverage for Laser Interstitial Thermal Therapy
Monteris Medical, a frontrunner in minimally invasive neurosurgical innovations, has made a monumental advancement by securing TRICARE coverage for laser interstitial thermal therapy (LITT) tailored for U.S. military service members and their families. This pivotal policy change marks a significant first step, ensuring over nine million eligible individuals gain access to cutting-edge surgical options for complex brain conditions like primary and metastatic tumors, radiation necrosis, and drug-resistant epilepsy.
A New Era of Access to Neurosurgery
The announcement, made on January 28, 2026, reflects a commitment to improving healthcare access for military families facing critical health challenges. By advocating for this policy change, Monteris Medical worked hand-in-hand with a diverse consortium of more than 30 military and veteran service organizations, unifying voices to urge the Defense Health Agency to modify the TRICARE guidelines. This collaborative effort sought not only to align TRICARE with Medicare and leading commercial insurers but also to spotlight the clinical evidence showcasing the benefits and cost-effectiveness of LITT.
According to U.S. Representative Gen. Jack Berger (R-MI), who played a crucial role in championing the policy alteration, the trust of military personnel and veterans in the healthcare system rests heavily during their most vulnerable moments. “Military families deserve the absolute best care available, and that includes advanced minimally invasive options for brain surgery,” Berger stated. He expressed pride in this decision, calling it a significant win for military medicine and a reflection of what can be accomplished when prioritizing the needs of those serving the nation.
Understanding LITT and Its Advantages
What sets LITT apart is its innovative approach to treating abnormal brain tissue. Utilizing laser energy, the procedure is performed under magnetic resonance (MR) guidance, allowing for precise ablation of targeted tissues through a small incision. The NeuroBlate System, Monteris Medical’s flagship platform, stands out as the only LITT system equipped with robotic capabilities and enhanced surgical visualization. This technology provides neurosurgeons with unparalleled precision and control, significantly optimizing surgical outcomes.
Clinical evidence demonstrates that patients undergoing LITT can expect shorter hospital stays, reduced complication rates, and similarly effective results compared to traditional brain surgery—all without the extensive invasiveness that often accompanies open surgery.
Martin J. Emerson, CEO of Monteris Medical, emphasized the transformative potential of laser ablation for patients with serious neurological disorders. “It is an honor to collaborate with military advocates and U.S. policymakers to ensure our military personnel and their families can access this groundbreaking technology,” he remarked, reaffirming the shared dedication to advancing medical care for these brave individuals.
Future Implications for Military Health Care
As Monteris Medical continues to explore further advancements in neurosurgery, the response from military families has been overwhelmingly positive. The successful integration of TRICARE coverage for LITT signifies not just access to a minimally invasive treatment but represents a robust commitment to addressing the healthcare challenges faced by service members and their relatives. This achievement could pave the way for additional policy changes aiming to enhance healthcare options for military personnel, ensuring that cutting-edge technological advancements reach those most in need.
For further insights on the NeuroBlate System and its capabilities in minimally invasive brain surgery, visit
monteris.com. The future of military healthcare is bright, as Monteris Medical leads the way in transforming how we think about and approach surgical treatments for complex neurological conditions.